focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,440.00
Bid: 2,435.00
Ask: 2,445.00
Change: 20.00 (0.83%)
Spread: 10.00 (0.411%)
Open: 2,425.00
High: 2,445.00
Low: 2,420.00
Prev. Close: 2,420.00
MGNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

21 Nov 2019 09:21

RNS Number : 2057U
Morgan Sindall Group PLC
21 November 2019
 

MORGAN SINDALL GROUP PLC

 

21 November 2019

Director Shareholding

 

Morgan Sindall Group plc (the Company) announces that it has been notified of the following transaction in the Company's ordinary 5p shares undertaken by John Morgan, Chief Executive.

 

On 20 November 2019, John Morgan exercised 106,364 share options which were granted to him under the rules of the Company's Executive Remuneration Plan 2005 on 17 March 2010 at an option price of £5.55 per share. These options were due to lapse on 16 March 2020 if not exercised. He subsequently sold these shares at a market price of £13.64 per share. John Morgan's interests in the ordinary shares of the Company are unchanged a result of this transaction at 4,284,519 shares.

 

The following notification is intended to satisfy the Company's obligations under Article 19.3 of EU Regulation No 596/2014 (the Market Abuse Regulation).

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

John Christopher Morgan

2

 

Reason for the notification

a)

 

Position/status

Chief Executive

b)

 

Initial notification /Amendment

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

Morgan Sindall Group plc

b)

 

LEI

2138008339ULDGZRB345

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 5p

 

 

Identification code

GB0008085614

 

 

b)

 

Nature of the transaction

 

 

Acquision of 106,364 at £5.55 per share following the exercise of share options granted in 2010 under Part B of the Morgan Sindall Executive Remuneration Plan 2005 and subsequent sale of 106,364 shares at £13.64 per share.

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

 

 

 

£13.64

106,364

 

 

 

 

 

 

d)

 

Aggregated information

N/a single transaction

- Aggregated volume

 

- Price

 

 

 

e)

 

Date of the transaction

 

20 November 2019

f)

 

Place of the transaction

 

London Stock Exchange (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLIFFALILLFIA
Date   Source Headline
18th Mar 202211:57 amRNSDirector/PDMR Shareholding
16th Mar 20223:03 pmRNSDirector/PDMR Shareholding
16th Mar 20229:23 amRNSDirector/PDMR Shareholding
16th Mar 20229:21 amRNSDirector/PDMR Shareholding
8th Mar 20224:00 pmRNSAdditional Listing
8th Mar 20228:27 amRNSHolding(s) in Company
7th Mar 20221:55 pmRNSDirector/PDMR Shareholding
7th Mar 20221:51 pmRNSDirector/PDMR Shareholding
4th Mar 20224:04 pmRNSDirector/PDMR Shareholding
4th Mar 20224:00 pmRNSDirector/PDMR Shareholding
1st Mar 20222:39 pmRNSTotal Voting Rights
24th Feb 20227:00 amRNSFinal Results
7th Feb 20227:00 amRNSNotice of Results
1st Feb 202211:41 amRNSTotal Voting Rights
4th Jan 20223:15 pmRNSTotal Voting Rights
21st Dec 202111:42 amRNSDirector Declaration
7th Dec 20212:26 pmRNSAdditional Listing
30th Nov 20214:53 pmRNSTotal Voting Rights
9th Nov 202112:51 pmRNSAdditional Listing
3rd Nov 20217:00 amRNSTrading Update
1st Nov 20219:24 amRNSTotal Voting Rights
20th Oct 202110:57 amRNSBlock listing Interim Review
20th Oct 20218:43 amRNSChange in Directors' Details
7th Oct 20218:44 amRNSAdditional Listing
4th Oct 20213:27 pmRNSHolding(s) in Company
1st Oct 20219:50 amRNSTotal Voting Rights
24th Sep 20218:00 amRNSHolding(s) in Company
22nd Sep 20218:19 amRNSHolding(s) in Company
7th Sep 20211:19 pmRNSAdditional Listing
2nd Sep 20217:26 amRNSHolding(s) in Company
1st Sep 202111:44 amRNSTotal Voting Rights
10th Aug 20213:13 pmRNSAdditional Listing
9th Aug 20214:26 pmRNSDirector/PDMR Shareholding
4th Aug 20217:00 amRNSHalf-year Report
2nd Aug 20219:37 amRNSTotal Voting Rights
22nd Jul 20217:00 amRNSTrading Update and Outlook for 2021
13th Jul 20217:00 amRNSNotice of Results
1st Jul 20211:22 pmRNSTotal Voting Rights
21st Jun 20215:34 pmRNSHolding(s) in Company
15th Jun 20212:30 pmRNSAdditional Listing
1st Jun 202111:12 amRNSTotal Voting Rights
18th May 20212:00 pmRNSAdditional Listing
6th May 202112:32 pmRNSResult of AGM
6th May 20217:00 amRNSAGM Statement
4th May 20219:05 amRNSTotal Voting Rights
23rd Apr 20213:04 pmRNSHolding(s) in Company
23rd Apr 20218:49 amRNSHolding(s) in Company
22nd Apr 20213:33 pmRNSDirector/PDMR Shareholding
22nd Apr 20217:00 amRNSTrading Update
21st Apr 20219:21 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.